Medical Device Lawsuit Alerts
- Petitions for Inter Partes Review by Nevro Corp. of Boston Scientific Neuromodulation Corporation’s U.S. Patent No. 6,895,280
- Petition for Inter Partes Review by Fisher & Paykel Healthcare Limited of ResMed Limited’s U.S. Patent No. 8,960,196
- Petition for Inter Partes Review by Analytics For Life, Inc. of 8825319 Canada Limited’s U.S. Patent No. 9,131,864
- Barry v. Depuy Synthes (new lawsuit filed)
- Barry v. Globus Medical, Inc. (new lawsuit filed)
- My Nemesis, v. Edan USA (new lawsuit filed)
- Ethicon et al v. Intuitive Surgical et al (new lawsuit filed)
- Petitions for Inter Partes Review by Cook Group Inc. of Boston Scientific Scimed, Inc.’s U.S. Patent No. 9,271,731
- Petition for Inter Partes Review by Edwards Lifesciences Corporation of Boston Scientific Scimed, Inc.’s U.S. Patent No. 6,915,560 (Petition granted in part and denied in part)
- Puget BioVentures v. Stryker et al (new lawsuit filed)
Recent Medical Device News
- KKR to Acquire WebMD for $2.8 Billion
- Sientra to Acquire Miramar Labs
- Sonavex Raises $3 Million
- Axonics Raises $14.5M
- Becton Dickinson to Acquire Bard for $24 Billion
- Outset Medical raises $76.5M
- JNJ/Codman Neuro Announces Acquisition Of Neuravi Limited
- 410 Medical raises $3.3M
- Boston Scientific acquires Symetis for $435 Million
- Mylan recalls 80,000 EpiPens
Trump Administration Policy Statement Calls for FDA Premarketing Activities to be Funded Entirely by Industry Fees
The Trump White House released a Statement of Administration Policy on Wednesday in response to the House of Representatives’ passage of H.R. 2430, a bill that would reauthorize the use of four FDA user fee programs: the Prescription Drug User Fee Act, the Medical Device User Fee Amendments, the Generic Drug User Fee Amendments, and the Biosimilar User Fee Act.
The Trump Administration’s Statement includes the following recommendation:
"The Administration urges the Congress to provide for 100 percent user fee funding within the reauthorized programs. In an era o...
Share